June 2025 in “Medical alphabet” JAK inhibitors may help treat alopecia areata in children, but their safety needs careful evaluation.
December 2015 in “International Journal of Ayurvedic Medicine” The review lists substances from an ancient text that are good for hair health.
April 2025 in “The Journal of Dermatology” Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.
June 2025 in “Patient Preference and Adherence” Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.
96 citations
,
December 2015 in “JAMA dermatology” Topical Ruxolitinib may safely treat severe hair loss.
Aloe vera hair tonic with 10% and 15% concentrations effectively promoted hair growth in male rats.
January 2025 in “International journal of Indian medicine” Certain herbs in Ayurveda are effective for hair growth, darkening, and health.
October 2025 in “Journal of Drug Delivery and Therapeutics” Senna Makki is mainly effective as a laxative, but more research is needed for other uses.
25 citations
,
March 2017 in “International Journal of Dermatology” Ruxolitinib effectively and safely regrows hair in alopecia patients.
September 2023 in “Journal of the American Academy of Dermatology” Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.
August 2022 in “Zenodo (CERN European Organization for Nuclear Research)” The herbal hair dye effectively provides a natural reddish-brown color without synthetic chemicals.
Herbal remedies like Ashwagandha, Amla, Bringraj, and Liquorice can effectively treat hair loss with few side effects.
2 citations
,
February 2021 in “IOP Conference Series Earth and Environmental Science” Mangkokan leaf contains various beneficial compounds like alkaloids, flavonoids, and steroids.
12 citations
,
August 2019 in “Dermatitis” Dupilumab for skin problems might reactivate hair loss in some patients.
August 2021 in “Revista Colombiana de Reumatología/Revista Colombiana de Reumatologia” Janus kinase inhibitors may effectively treat severe alopecia areata unresponsive to other treatments.
2 citations
,
May 2022 in “Journal of the American Academy of Dermatology” The study concludes that Traction Alopecia is often overlooked in women and children of color, and better recognition and follow-up care are needed.
1 citations
,
August 2021 in “Journal of Investigative Dermatology” ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.
Deuruxolitinib is approved to treat severe alopecia areata in adults.
February 2005 in “Journal of the American Academy of Dermatology”
May 2023 in “Authorea (Authorea)” Levofloxacin may cause skin discoloration and hair loss as side effects.
October 2025 in “International Journal of Dermatology” JAK inhibitors may help treat certain types of hair loss, but more research is needed.
August 2024 in “Panggung Kebaikan” Education increased awareness of using clove leaves for hair growth.
4 citations
,
May 2025 in “Frontiers in Immunology” JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.
July 2023 in “Media Dermato Venereologica Indonesiana” Vitamin D supplements should be used cautiously in sarcoidosis patients, with regular monitoring to avoid high calcium levels.
6 citations
,
November 1996 in “Archives of Dermatology” A man's relapsed leprosy was successfully treated with the antibiotic sparfloxacin.
February 2026 in “Indian Journal of Skin Allergy” Ruxolitinib cream effectively treats skin conditions like atopic dermatitis and vitiligo with minimal side effects.
January 2025 in “International Journal for Research in Applied Science and Engineering Technology” Eclipta alba promotes hair growth and supports liver health.
Smilax aristolochiifolia is less abundant due to environmental changes, but still used in traditional medicine.
September 2025 in “Chinese Journal of Chromatography” A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.
January 2024 in “Elsevier eBooks”